Source: Annual Congress 2011 - PG9 Risk stratification and treatment of lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Welte (Hannover, Germany). Predictors of clinical failure in community-acquired pneumonia. Annual Congress 2011 - PG9 Risk stratification and treatment of lower respiratory tract infections

Member's Comments

No comment yet.

Related content which might interest you: Clinical failure in community-acquired pneumonia Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases Year: 2014 Cost of treatment failure in community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 195s Year: 2007 Predictors of rehospitalization after admission for community-acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Biomarkers as complication predictors in community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Community-acquired pneumonia: treatment failure and complications Source: ERS Course 2018 - Respiratory Infections Year: 2018 Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 Etiology and clinical outcome of community-acquired pneumonias in hospitalized children Source: Eur Respir J 2007; 30: Suppl. 51, 398s Year: 2007 Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015 Treatment failure of severe and ventilator-associated pneumonia Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia Source: Eur Respir J 2009; 34: 932-939 Year: 2009 Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2013; 42: 742-749 Year: 2013 Analysis of mortality from community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006 How to recognize clinical stability in hospitalized patients with community-acquired pneumonia (CAP)? Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia Year: 2011 Severe community-acquired pneumonia Source: Eur Respir Monogr 2016; 74: 101-116 Year: 2016